In particular, the level of leptin, an adipokine with numerous proinflammatory effects, is increased in AD patients [21], while adiponectin, which seems to have an anti-inflammatory role, is found at lower levels in patients with AD [21,22]. This evidence concerns the gene ADIPOQ and Alzheimer disease.